Planned sale of 1,905 shares in CFLT (NASDAQ: CFLT) after 10b5-1 trades
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
A shareholder of CFLT has filed a Form 144 notice to potentially sell 1,905 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of 58140.60 and an approximate sale date of 02/13/2026.
The shares were acquired on 09/26/2014 via an in-kind distribution post-IPO from the issuer. Over the past three months, 10b5-1 plan sales for The Vishria Revocable Trust and The Khakal Trust included 15,000-share transactions on 12/10/2025 and 12/08/2025 with gross proceeds of 450000.00 and 447600.00, plus 476-share sales on the same dates with proceeds of 14280.00 and 14203.84. The signing party represents they do not know any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for CFLT disclose?
The Form 144 filing discloses an intended sale of 1,905 CFLT common shares. The shares have an aggregate market value of $58,140.60, are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of February 13, 2026.
What prior CFLT stock sales are referenced in this Form 144?
The filing lists recent 10b5-1 sales by The Vishria Revocable Trust and The Khakal Trust. These include 15,000-share sales on December 8 and 10, 2025 and 476-share sales on both dates, with individual gross proceeds ranging from $14,203.84 to $450,000.00.
What representation does the seller make in the CFLT Form 144?
The seller represents they do not know any material adverse information about CFLT’s current or prospective operations that has not been publicly disclosed. This representation is made when signing the notice and is tied to any Rule 10b5-1 trading plan adoption date.